121 related articles for article (PubMed ID: 3567370)
21. Increase of NK cell-mediated cytotoxicity of hairy cell leukemia patients after splenectomy.
Bigda J; Myśliwska J; Baran V; Zoltowska A; Hellmann A
Eur J Haematol; 1989 Jul; 43(1):78-9. PubMed ID: 2767244
[No Abstract] [Full Text] [Related]
22. Strategy for the treatment of hairy cell leukemia.
Porzsolt F; Raghavachar A; Digel W; Raghavachar A; Bartram CR; Heimpel H
Leukemia; 1987 Apr; 1(4):334-7. PubMed ID: 3669758
[TBL] [Abstract][Full Text] [Related]
23. Interleukin 2- and interferon alpha induced natural killer cell activity as a marker of progression in hairy cell leukemia.
Bigda J; Mysliwska J; Baran W; Hellmann A; Mysliwski A
Leuk Lymphoma; 1993 Mar; 9(4-5):371-6. PubMed ID: 8348073
[TBL] [Abstract][Full Text] [Related]
24. Flow cytometric study on phagocyte function and determination of in vitro natural killer (NK) cell cytotoxicity in hairy cell leukaemia (HCL). Comparison with values obtained following post-traumatic splenectomy (SP).
Demeter J; Mihalik R; Pálóczi K; Benczur M
Acta Paediatr Hung; 1988-1989; 29(1-2):219-20. PubMed ID: 3255408
[No Abstract] [Full Text] [Related]
25. Severe deficiency of natural killer activity in the peripheral blood of patients with hairy cell leukemia.
Ruco LP; Procopio A; Maccallini V; Calogero A; Uccini S; Annino L; Mandelli F; Baroni CD
Blood; 1983 Jun; 61(6):1132-7. PubMed ID: 6220750
[TBL] [Abstract][Full Text] [Related]
26. Hairy cell leukaemia: observations on natural killer activity in different clinical stages of the disease.
Demeter J; Pálóczi K; Lehoczky D; Benczúr M
Br J Haematol; 1989 Feb; 71(2):239-44. PubMed ID: 2923810
[TBL] [Abstract][Full Text] [Related]
27. Phenotypic and functional characterization of the circulating NK compartment in hairy cell leukaemia.
Foa R; Lauria F; Lusso P; Raspadori D; Fierro MT; Tazzari PL; Caudana L; Matera L
Clin Exp Immunol; 1986 May; 64(2):392-8. PubMed ID: 3742880
[TBL] [Abstract][Full Text] [Related]
28. Demonstration of the increase in serine esterase-positive T cells in hairy-cell leukemia patients undergoing alpha-interferon therapy.
Wagner L; Goldstone AH; Worman CP
Leukemia; 1989 May; 3(5):373-9. PubMed ID: 2497282
[TBL] [Abstract][Full Text] [Related]
29. Successful treatment of T-hairy cell leukemia with lymphoblastoid-interferon.
Rossi E; Gualandi F; Lamparelli T; Repetto M; Nocera A; Spriano M; Occhini D; Ruggeri C; Vimercati R; Damasio EE
J Exp Pathol; 1987; 3(4):593-601. PubMed ID: 3502652
[No Abstract] [Full Text] [Related]
30. Effect of recombinant human interferons on NK and K cell activities of gnotobiotic miniature swine.
Kim YB; Chung TJ
Prog Clin Biol Res; 1985; 181():329-32. PubMed ID: 3927308
[No Abstract] [Full Text] [Related]
31. Studies on the optimal dose and the mode of action of alpha-interferon in the treatment of hairy cell leukemia.
Huber C; Aulitzky W; Tilg H; von Lüttichau I; Troppmair J; Nachbauer K; Gastl G
Leukemia; 1987 Apr; 1(4):355-7. PubMed ID: 3669762
[TBL] [Abstract][Full Text] [Related]
32. [Clear-cell carcinoma of the kidney in a patient with hairy-cell leukemia. Immunologic and epidemiologic considerations].
Buffa G; Marino G; Cocimano V; Capaldi A; Torchio B
Minerva Urol Nefrol; 1990; 42(4):231-4. PubMed ID: 2095639
[TBL] [Abstract][Full Text] [Related]
33. Recombinant leukocyte A interferon therapy for advanced hairy cell leukemia. Therapeutic and immunologic results.
Foon KA; Maluish AE; Abrams PG; Wrightington S; Stevenson HC; Alarif A; Fer MF; Overton WR; Poole M; Schnipper EF
Am J Med; 1986 Mar; 80(3):351-6. PubMed ID: 3953613
[TBL] [Abstract][Full Text] [Related]
34. Alpha-interferon in hairy cell leukaemia: direct effects on hairy cells or indirect cytotoxicity?
Sigaux F; Castaigne S; Lehn P; Dupuy E; Billard C; Gluckman JC; Boiron M; Falcoff E; Flandrin G; Degos L
Int J Cancer Suppl; 1987; 1():2-8. PubMed ID: 3476473
[TBL] [Abstract][Full Text] [Related]
35. [Hairy-cell leukemia as a model for studying the effects of interferon on the immune system].
Semenzato G; Trentin L; Bulian P; Agostini C; Chisesi T; Pizzolo G
Haematologica; 1990; 75 Suppl 4():10-9. PubMed ID: 1705910
[No Abstract] [Full Text] [Related]
36. Modulation of the response to B-cell growth factor (BCGF) of hairy cells from a patient under IFN-alpha therapy.
Génot E; Mathiot C; Kolb JP
Blut; 1987 Jul; 55(1):65-7. PubMed ID: 3496931
[No Abstract] [Full Text] [Related]
37. Alpha-interferon in myelodysplasia; clinical observations and effects on NK cells.
Galvani DW; Nethersell AB; Cawley JC
Leuk Res; 1988; 12(3):257-62. PubMed ID: 3163399
[TBL] [Abstract][Full Text] [Related]
38. Successful use of interferon alfa-n1 in the treatment of hairy cell leukemia.
Cawley JC; Bottomley JM; Worman CP
Med Clin North Am; 1986 May; Suppl():37-9. PubMed ID: 3488481
[TBL] [Abstract][Full Text] [Related]
39. An interferon resistant variant of the hairy-cell leukemic cell line, Eskol: biochemical and immunological characterization.
Ozes ON; Klein SB; Reiter Z; Taylor MW
Leuk Res; 1993 Nov; 17(11):983-90. PubMed ID: 7694002
[TBL] [Abstract][Full Text] [Related]
40. Natural killer lymphocytes in hairy cell leukemia: presence of phenotypically identifiable cells with defective functional activity.
Smith BR; Rosenthal DS; Ault KA
Exp Hematol; 1985 Mar; 13(3):189-93. PubMed ID: 3884356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
